ADiTx Inc (ADTX): Agreed. I got some too. One never knows...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	196
Posts	13482
Boards Moderated	0
Alias Born	06/20/2022

Invest-in-America

Re: A deleted message

Friday, 07/08/2022 10:50:17 AM

Friday, July 08, 2022 10:50:17 AM

Agreed. I got some too. One never knows with this Medical stuff, but looks like this Company has an extremely SAFE way of doing what they do.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ADTX News

Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:20:52 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2026 08:20:06 PM
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 • Business Wire • 05/14/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 08:20:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:35:47 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/23/2026 08:30:42 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/22/2026 04:15:21 AM
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients • Business Wire • 04/20/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 12:00:13 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/11/2026 01:49:19 AM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/07/2026 08:02:58 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2026 08:37:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:13:36 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:35:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 12:00:37 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/27/2026 09:02:12 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/24/2026 09:21:36 PM
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer • Business Wire • 03/19/2026 12:15:00 PM
Aditxt Acquires Ignite Proteomics to Expand Precision Oncology Capabilities • IH Market News • 03/13/2026 03:36:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 12:35:24 PM
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection • Business Wire • 03/13/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:30:35 PM
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026 • Business Wire • 03/05/2026 01:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 10:03:05 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent ADTX News

More ADTX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ADTX News

Go Ad-Free